Pediatric Dilated Cardiomyopathy Workup
- Author: Poothirikovil Venugopalan, MBBS, MD, FRCP(Glasg), FRCPCH; more...
Approach Considerations
Echocardiography and Doppler studies form the basis for the diagnosis of dilated cardiomyopathy (DCM) in most patients. Cardiomegaly that is incidentally detected on a chest radiograph or an arrhythmia that is incidentally detected on an electrocardiogram (ECG) may be the basis for initial cardiac referral.
ECG changes are usually nonspecific. The main role of ECG is to detect evidence of myocardial ischemia that might point to an anomalous coronary artery as the etiology of the cardiomyopathy.
Cardiac catheterization studies, angiography, and myocardial biopsy are preformed principally as preparation for cardiac transplantation.
Blood Studies
The complete blood count, erythrocyte sedimentation rate, and C-reactive protein level may show evidence of acute inflammation in patients with dilated cardiomyopathy (DCM) in the presence of active myocarditis. Similarly, creatine kinase–myocardial fraction may be elevated.
Rising titers of specific viral-neutralizing antibodies in the serum and positive viral cultures from nasopharyngeal or stool swabs may suggest a viral etiology; however, this does not necessarily mean a cause-and-effect relationship.
Serum carnitine levels (total and free) are low when the disease is due to systemic carnitine deficiency.
Arterial blood gas (ABG) analysis reveals early stages of mild respiratory alkalosis and, later, mild hypoxemia secondary to pulmonary edema. In advanced disease, mixed acid-base disturbances with metabolic acidosis indicate the need for intravenous inotropes and ventilatory assistance.
Chest Radiography
Chest radiography reveals cardiomegaly with a prominent left ventricular apex and prominent pulmonary artery segment. (See the image below.)
Chest radiograph of a child with idiopathic dilated cardiomyopathy. Elevation of left main bronchus reflects dilation of the left atrium. This can result in compression of the left lower lobe bronchus when combined with a dilated pulmonary artery, leading to collapse of the left lower lobe of the lung.
Pulmonary venous congestion and frank pulmonary edema are often evident. When present, pleural effusion is better appreciated in the erect and lateral decubitus films.
Massive cardiomegaly resembling pericardial effusion is the hallmark of established disease.
Rarely, in fulminant cases, cardiomegaly may not be prominent because the ventricle has not had time to dilate despite the presence of features of pulmonary edema.
Echocardiography and Doppler Studies
These form the basis for the diagnosis of DCM in most patients. Marked dilation of the left ventricle with global hypokinesia is the hallmark of the disease. Left ventricular fractional shortening is usually less than 25% (ejection fraction < 50%). Left ventricular walls are thin and areas of dyskinesis may be observed.
The left atrium is also dilated, and mitral valve leaflets show sluggish movement; the anterior leaflet does not appose to the interventricular septum, giving an increased E point septal separation on the M-mode pictures. (See the images below.) The M-mode also clearly reveals the limited excursions of the anterior and posterior leaflets during diastole.
Echocardiogram obtained from apical 4-chamber view revealing a dilated left atrium and left ventricle in a child with idiopathic dilated cardiomyopathy.
This is an echocardiogram obtained from parasternal long axis view revealing a dilated left atrium and left ventricle in a child with idiopathic dilated cardiomyopathy. Doppler studies show varying degrees of mitral regurgitation secondary to left ventricular dilation and possible papillary muscle dysfunction. See image below. Mitral regurgitation is more prominent in follow-up studies after commencing therapy when the cardiac output has improved. Left ventricular ejection parameters show decrease in peak velocity and peak acceleration, prolongation of the pre-ejection period, and decrease in ejection time. These flow measurements are dependent on loading conditions.
This is a color Doppler echocardiogram obtained from apical 4-chamber view revealing a dilated left atrium and left ventricle with the blue jet of mitral regurgitation in a child with idiopathic dilated cardiomyopathy. Mild tricuspid regurgitation is also shown. The dilatation of the mitral valve ring and the altered shape of the left ventricle cavity, which lead to change in the direction of the papillary muscles, are used to explain the secondary mitral regurgitation seen in a large proportion of children with DCM. Tissue Doppler studies have recently been reported in children with DCM.
Parameters of diastolic dysfunction are not reliable in the presence of established systolic dysfunction and mitral regurgitation; however, they may be useful in the early stages of the disease. Diastolic dysfunction is not as typical or as pronounced as it is in hypertrophic cardiomyopathy.
More detailed evaluation of mechanical dyssynchrony and its association with clinical status in children with DCM is increasingly used in specialized centers in an attempt to predict outcome.[25] The standard deviation of QRS to peak systolic velocity interval using tissue Doppler can be measured in 12 left ventricular segments as a dyssynchrony index (DI). DI reference ranges for children have not been established; the current adult-defined DI reference ranges are used to define dyssynchrony.
Longitudinal function can be assessed by serial measurements of the mitral and tricuspid valve displacements in systole. Speckle tracking strain can complement tissue Doppler imaging in identification of dyssynchrony.[26] Real time 3-dimensional echocardiography also helps to assess for dyssynchrony.[27]
Long-standing cases show evidence of pulmonary hypertension in the form of right ventricular dilation and hypertrophy and tricuspid regurgitation. Tricuspid regurgitation and pulmonary regurgitation velocities give an estimate of the pulmonary artery systolic and diastolic pressures respectively.
In severe cases, swirling echodensity (smoke or spontaneous echocardiographic contrast) can be observed along the outer ventricular wall, moving from the mitral valve towards the aortic valve. Occasionally, thrombi can be visualized in the left ventricular apex and in the left atrium. Pericardial effusion also may be present.
Echocardiography can exclude other heart diseases, both congenital and acquired. Cardiomyopathy secondary to severe aortic stenosis, coarctation of aorta or congenital mitral valve dysplasia, and anomalous left coronary artery arising from pulmonary artery (ALCAPA) are the major differential diagnoses.
At times, identifying cardiomyopathy secondary to congenital mitral regurgitation (dysplastic mitral valve without stenosis) is difficult, but the abnormal anatomy of the mitral valve leaflets should help. The echo-dense papillary muscles and the dilated proximal right coronary artery and continuous retrograde flow of blood into the origin of pulmonary artery all direct the attention of the cardiologist to ALCAPA, a potentially treatable condition that mimics DCM.
Early diagnosis of DCM from anthracycline toxicity requires periodic Doppler echocardiography studies during therapy and for several years after cessation of treatment. It also requires more widespread use of load-independent measurements of cardiac contractility (eg, stress velocity index), which incorporate measurements of contractility, afterload, and preload.
Radionuclide Imaging
First-pass test and multiple gated acquisition (MUGA) scans help to measure the left and right ventricular stroke volumes and cardiac outputs. They are also helpful in documenting dyskinetic segments in the ventricular walls. Although theoretically superior to echocardiographic measurements, their practical application is limited because of a lack of standardization and because of nonreproducibility, especially in children.
Thallium studies can identify areas of decreased myocardial perfusion, although this is seldom required.
Gallium-67 citrate (Ga-67) scintigraphy and indium-111 (In-111) altumomab pentetate antimyosin antibody cardiac imaging have been suggested to help identify ongoing inflammation noninvasively. They may be used to identify patients who might benefit from myocardial biopsy.
Electrocardiography
ECG changes are usually nonspecific. Some patients have the following findings:
- Sinus tachycardia
- Downward frontal plane QRS axis
- Left atrial enlargement
- Left ventricular hypertrophy
- Deep Q waves with ST segment depression
- Tall T waves in leads I, aVL, V5, V6 (these reflect left ventricular volume overload)
In more advanced disease, right-axis deviation, right atrial enlargement, and right ventricular hypertrophy are seen. These result from pulmonary hypertension.
The main role of ECG is to detect evidence of myocardial ischemia (pathologic Q waves with ST elevation and T-wave inversion in leads I, aVL, V5, V6) that might point to anomalous coronary artery as the etiology of the cardiomyopathy. A segmental myocarditis may result in ECG features of myocardial infarction.
Cardiac arrhythmias, such as supraventricular/ventricular ectopy or tachycardia, may be revealed. These might indicate an underlying myocarditis or cardiomyopathy. On the other hand, if the arrhythmia is sustained, it may be the cause of the cardiomyopathy rather than the result (ie, tachycardia-mediated cardiomyopathy).
Cardiac Catheterization and Angiography
Children with DCM are at a particular risk for complications during cardiac catheterization studies and angiography. Procedures should be performed by experienced pediatric cardiologists and only when absolutely essential.
At present, preparation for cardiac transplantation and need for myocardial biopsy are the main indications for performing the procedure. Patients should be under optimum medical therapy and kept hemodynamically stable before and after catheterization. Careful observation is required during the procedure for ventricular arrhythmias and hemodynamic deterioration.
Echocardiography should be considered after catheterization to identify any pericardial effusion secondary to subclinical perforation of the myocardium, especially if a biopsy has also been performed. Aortography may be performed to identify coronary artery anatomy, and left ventricular angiography may be performed to assess mitral valve function. The number of biopsy specimens collected should be limited to the minimum required (usually 4-8).
Usual findings include elevated filling pressures in all the cardiac chambers (especially the left ventricle), elevated pulmonary wedge pressure, and reduced cardiac output and stroke volume. Mixed venous oxygen saturation and reduced arterial saturation reflect low cardiac output and pulmonary edema. Pulmonary and systemic vascular resistances are elevated. With end-stage disease, the peak systolic left ventricular and aortic pressures drop.
Myocardial Biopsy
At present, preparation for cardiac transplant and post-transplant follow-up monitoring for rejection are the main indications for biopsy. If facilities are available, molecular or metabolic studies can be additional indications for academic and research purposes. Rarely, suspected metabolic diseases (eg, isolated myocardial carnitine deficiency, rare forms of glycogen storage disease, fatty acid oxidation defects) or persistent myocarditis might require biopsy for confirmation. The most important aspect is the availability of a sufficient level of expertise for interpretation of the findings.
Specimens should be subjected to both light and electron microscopy. Polymerase chain reaction (PCR) and metabolic studies should be performed when indicated. Histologic features are nonspecific in most patients and include myocardial cell loss with varying degree of necrosis and fibrosis. In the presence of myocarditis, lymphocytic infiltration of varying degree is also present (Dallas criteria).
PCR has been used to aid the detection of viral antigens in myocardial tissue in patients with DCM.[6, 7] Studies have revealed an association between viral antigens and DCM. However, a proportion of the studies gave negative results. A meta-analysis of the studies on DCM gave an odds ratio of 3.8 to the association between presence of viral antigens in DCM.
The results of PCR studies are influenced by such factors as contamination from the reference strain used in the laboratory and choice of the controls. It also is not clear whether these positive cases among DCM actually represented acute myocarditis rather than DCM.
The Two Steps to Diagnosis
Step-by-step charts (see Tables 3 and 4, below) guide the evaluation of children with suspected DCM to help clinicians arrive at a firm diagnosis.
Making the diagnosis
Table 3. Diagnosis of Dilated Cardiomyopathy in Children - Step I: Diagnosis (Open Table in a new window)
| Approach | Findings | Conclusion |
| Clinical suspicion | Infants and young children: Shortness of breath, feeding difficulties, wheezing, failure to thrive, recurrent chest infections, hepatomegaly, cardiomegaly Older children: Dyspnea, dependent edema, elevated jugular venous pressure, cardiomegaly | Probable heart disease with heart failure |
| Chest radiography | Cardiomegaly, pulmonary plethora, prominent upper lobe veins, pulmonary edema, pleural effusion, collapsed left lower lobe | High probability of heart failure with or without chest infection |
| Electrocardiography | Low-voltage complexes | Pericardial effusion |
| Presence of Q waves and inversion of T waves in leads I, II, aVL, and V4 through V6 (anterolateral infarction pattern) | Anomalous left coronary artery from pulmonary artery | |
| Significant arrhythmia | Dilated cardiomyopathy secondary to arrhythmia | |
| Left ventricular or biventricular hypertrophy with or without left ventricular strain pattern | Often unhelpful | |
| Doppler echocardiographic studies | Significant congenital heart disease | Diagnose primary disease |
| Significant pericardial effusion with satisfactory left ventricular ejection fraction | Diagnose pericardial effusion | |
| Left ventricular posterior wall hypokinesia with hyperechoic papillary muscles, retrograde continuous flow into proximal pulmonary artery | Diagnose anomalous left coronary artery from pulmonary artery | |
| Dilated left ventricle (>95th percentile) with global hypokinesia (fractional shortening < 25%, ejection fraction < 50%), and no demonstrable structural heart disease | Diagnose dilated cardiomyopathy |
Identifying the etiology
Table 4. Diagnosis of Dilated Cardiomyopathy in Children - Step II: Identification of Any Underlying Etiology (Open Table in a new window)
| Approach | Findings | Conclusion |
| Clinical features | Positive family history | Genetic cause for dilated cardiomyopathy |
| Acute or chronic encephalopathy, muscle weakness, hypotonia, growth retardation, recurrent vomiting, lethargy | Inborn error of metabolism involving energy production | |
| Coarse or dysmorphic features, organomegaly, skeletal abnormalities, short stature, chronic encephalopathy, cherry-red spot in eyes | Storage diseases | |
| Skeletal muscle weakness without encephalopathy | Neuromuscular disorders | |
| Blood investigations | High blood urea nitrogen and creatinine levels, low calcium and magnesium levels, electrolyte disturbances | Help in the initial management; occasionally point to a cause of dilated cardiomyopathy, especially in neonates |
| Elevated acute-phase reactants and cardiac enzyme levels | Myocarditis | |
| Positive viral titers | Viral myocarditis | |
| Low serum carnitine levels | Systemic carnitine deficiency | |
| Hypoglycemia with low or no acidosis (ketosis) 1. High insulin levels, low free fatty acid 2. Low insulin levels, high free fatty acid | 1. Infant of diabetic mother, nesidioblastosis 2. Defect in fatty acid oxidation or carnitine metabolism | |
| Hypoglycemia with moderate or high acidosis (ketosis) 1. Low or normal lactate and abnormal urine and serum organic acid levels 1. High lactate | 1. Organic (propionic, methylmalonic) acidemias, or ß-ketothiolase deficiency 2. Glycogen storage disease, Bath and Sengers syndromes, pyruvate dehydrogenase deficiency, mitochondrial enzyme deficiency | |
| Hyperammonemia with acidosis | Organic acidemias (as above) | |
| Specific enzyme assay | Confirms enzymatic defect | |
| Absence of above physical and biochemical abnormalities | Post myocarditis or idiopathic dilated cardiomyopathy | |
| Cardiac catheterization | Evaluate hemodynamics | Useful to predict prognosis and evaluate for transplant |
| Coronary angiography | Abnormal origin of left coronary artery from pulmonary artery | Anomalous left coronary artery from pulmonary artery |
| Myocardial biopsy | Myocyte hypertrophy and fibrosis without lymphocytic infiltrate | Dilated cardiomyopathy |
| Inflammatory cell infiltration, cell necrosis | Myocarditis | |
| Special stains | Mitochondrial or infiltrative diseases | |
| Molecular studies (on blood, fibroblasts, or myocardial cells) | Nucleic acid hybridization studies Polymerase chain reaction studies | Myocarditis |
| DNA mutation analysis | Identifies specific genetic defect |
Akagi T, Benson LN, Lightfoot NE, et al. Natural history of dilated cardiomyopathy in children. Am Heart J. May 1991;121(5):1502-6. [Medline].
[Best Evidence] Andrews RE, Fenton MJ, Ridout DA, Burch M. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and Ireland. Circulation. Jan 1 2008;117(1):79-84. [Medline].
Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics. Mar 1998;101(3 Pt 1):369-76. [Medline].
Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. Jan-Feb 2010;52(4):274-88. [Medline].
Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. Aug 6 2003;42(3):466-72. [Medline].
Breinholt JP, Fraser CD, Dreyer WJ, et al. The efficacy of mitral valve surgery in children with dilated cardiomyopathy and severe mitral regurgitation. Pediatr Cardiol. Jan 2008;29(1):13-8. [Medline].
Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. Sep 2 2003;108(9):1146-62. [Medline].
Chen C, Heusch A, Donner B, Janssen G, Göbel U, Schmidt KG. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents. Klin Padiatr. May-Jun 2009;221(3):162-6. [Medline].
Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol. Jan 1990;15(1):189-93. [Medline].
Connuck DM, Sleeper LA, Colan SD, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. Jun 2008;155(6):998-1005. [Medline].
Dimas VV, Denfield SW, Friedman RA, Cannon BC, Kim JJ, Smith EO, et al. Frequency of cardiac death in children with idiopathic dilated cardiomyopathy. Am J Cardiol. Dec 1 2009;104(11):1574-7. [Medline].
Friedberg MK, Roche SL, Balasingam M, et al. Evaluation of mechanical dyssynchrony in children with idiopathic dilated cardiomyopathy and associated clinical outcomes. Am J Cardiol. Apr 15 2008;101(8):1191-5. [Medline].
Fujioka S, Kitaura Y, Ukimura A, et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. Nov 15 2000;36(6):1920-6. [Medline].
Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. Jan 1988;11(1):139-44. [Medline].
Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail. Mar 2009;15(2):83-97. [Medline].
Janousek J, Gebauer RA. Cardiac resynchronization therapy in pediatric and congenital heart disease. Pacing Clin Electrophysiol. Feb 2008;31 Suppl 1:S21-3. [Medline].
John JB, Cron SG, Kung GC, Mott AR. Intracardiac thrombi in pediatric patients: presentation profiles and clinical outcomes. Pediatr Cardiol. May-Jun 2007;28(3):213-20. [Medline].
Pahl E, Sleeper LA, Canter CE, et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy a report from the pediatric cardiomyopathy registry. J Am Coll Cardiol. Feb 7 2012;59(6):607-15. [Medline].
Kaushal S, Jacobs JP, Gossett JG, Steele A, Steele P, Davis CR, et al. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges. Cardiol Young. Nov 2009;19 Suppl 2:74-84. [Medline].
Kimura A. Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J. 2008;72 Suppl A:A38-48. [Medline].
Kovacevic-Preradovic T, Jenni R, Oechslin EN, Noll G, Seifert B, Attenhofer Jost CH. Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience. Cardiology. 2009;112(2):158-64. [Medline].
Labombarda F, Blanc J, Pellissier A, Stos B, Gaillard C, Bajolle F, et al. Health-e-Child project: mechanical dyssynchrony in children with dilated cardiomyopathy. J Am Soc Echocardiogr. Nov 2009;22(11):1289-95. [Medline].
Liu W, Li WM, Sun NL. Relationship between HLA-DQA1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy. Chin Med J (Engl). Oct 2004;117(10):1449-52. [Medline].
Malaisrie SC, Pelletier MP, Yun JJ, et al. Pneumatic paracorporeal ventricular assist device in infants and children: initial Stanford experience. J Heart Lung Transplant. Feb 2008;27(2):173-7. [Medline].
McMahon CJ, Pignatelli RH, Nagueh SF, et al. Left ventricular non-compaction cardiomyopathy in children: characterisation of clinical status using tissue Doppler-derived indices of left ventricular diastolic relaxation. Heart. Jun 2007;93(6):676-81. [Medline].
Michels VV, Driscoll DJ, Miller FA, et al. Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart. Jul 2003;89(7):757-61. [Medline].
Michels VV, Olson TM, Miller FA, et al. Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy. Am J Cardiol. Jun 1 2003;91(11):1389-92. [Medline].
Morales DL, Dreyer WJ, Denfield SW, et al. Over two decades of pediatric heart transplantation: how has survival changed?. J Thorac Cardiovasc Surg. Mar 2007;133(3):632-9. [Medline].
Norkiene I, Ringaitiene D, Rucinskas K, et al. Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: bridge to transplantation or assist device. Interact Cardiovasc Thorac Surg. Feb 2007;6(1):66-70. [Medline].
Rhee EK, Canter CE, Basile S, Webber SA, Naftel DC. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?. J Heart Lung Transplant. May 2007;26(5):447-52. [Medline].
Senes M, Erbay AR, Yilmaz FM, et al. Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy. Clin Chem Lab Med. 2008;46(3):382-6. [Medline].
Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. Sep 12 2007;298(10):1171-9. [Medline].
Singh TP, Sleeper LA, Lipshultz S, Cinar A, Canter C, Webber SA, et al. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. Nov 2009;2(6):591-8. [Medline].
Sonne C, Sugeng L, Takeuchi M, Weinert L, Childers R, Watanabe N, et al. Real-time 3-dimensional echocardiographic assessment of left ventricular dyssynchrony: pitfalls in patients with dilated cardiomyopathy. JACC Cardiovasc Imaging. Jul 2009;2(7):802-12. [Medline].
Stanton C, Bruce C, Connolly H, Brady P, Syed I, Hodge D, et al. Isolated left ventricular noncompaction syndrome. Am J Cardiol. Oct 15 2009;104(8):1135-8. [Medline].
Sugiyama H, Hoshiai M, Naitoh A, Kadono T, Suzuki S, Sugita K. Outcome of non-transplant surgical strategy for end-stage dilated cardiomyopathy in young children. Circ J. Jun 2009;73(6):1045-8. [Medline].
Tjang YS, Stenlund H, Tenderich G, et al. Risk factor analysis in pediatric heart transplantation. J Heart Lung Transplant. Apr 2008;27(4):408-15. [Medline].
Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. Oct 18 2006;296(15):1867-76. [Medline].
Vatta M, Sinagra G, Brunelli L, Faulkner G. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect. J Cardiovasc Med (Hagerstown). Feb 2009;10(2):149-56. [Medline].
Venugopalan P, Agarwal AK, Akinbami FO. Improved prognosis of heart failure due to idiopathic dilated cardiomyopathy in children. Int J Cardiol. Jul 1 1998;65(2):125-8. [Medline].
Venugopalan P, Houston AB, Agarwal AK. The outcome of idiopathic dilated cardiomyopathy and myocarditis in children from the west of Scotland. Int J Cardiol. Apr 2001;78(2):135-41. [Medline].
Pillekamp F, Khalil M, Emmel M, Brockmeier K, Hescheler J. Stem cells in pediatric heart failure. Minerva Cardioangiol. Jun 2008;56(3):335-48. [Medline].
- Table 1. Factors Identified as Causes of Myocardial Damage
- Table 2. Summary of Genetic Loci and Disease Genes for Familial Dilated Cardiomyopathy
- Table 3. Diagnosis of Dilated Cardiomyopathy in Children - Step I: Diagnosis
- Table 4. Diagnosis of Dilated Cardiomyopathy in Children - Step II: Identification of Any Underlying Etiology
| Category Of Factors | Specific Factors |
| Viral infections (myocarditis) | Coxsackievirus B, human immunodeficiency virus, echovirus, rubella, varicella, mumps, Epstein-Barr virus, cytomegalovirus, measles, polio |
| Bacterial infections | Diphtheria, Mycoplasma, tuberculosis, Lyme disease, septicemia |
| Rickettsia | Psittacosis, Rocky Mountain spotted fever |
| Parasites | Toxoplasma, Toxocara, Cysticercus |
| Fungi | Histoplasma, coccidioidomycoses, Actinomyces |
| Neuromuscular disorders | Duchenne or Becker muscular dystrophies, Friedreich ataxia, Kearns-Sayre syndrome, other muscular dystrophies |
| Nutritional factors | Kwashiorkor, pellagra, thiamine deficiency, selenium deficiency |
| Collagen vascular diseases | Rheumatic fever, rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, Kawasaki disease |
| Hematological diseases | Thalassemia, sickle cell disease, iron deficiency anemia |
| Coronary artery diseases | Anomalous left coronary artery from pulmonary artery, infarction |
| Drugs | Anthracycline, cyclophosphamide, chloroquine, iron overload |
| Endocrine diseases | Hypothyroidism, hyperthyroidism, hypoparathyroidism, pheochromocytoma, hypoglycemia |
| Metabolic disorders | Glycogen-storage diseases, carnitine deficiency, fatty acid oxidation defects, mucopolysaccharidoses |
| Malformation syndromes | Cri-du-chat (cat-cry) syndrome |
| Clinical Pattern | Identified Genetic Loci | Identified Disease Genes |
| Autosomal dominant (AD) | 10q21-10q23, 9q13-q22, 1q32, 15q14, 2q31, 1q11-21 | Actin, desmin, lamin A/C |
| AD with conduction defect | 1p1-1q1, 3p22-3p25 | ... |
| X-linked (XL) | Xp21 | Dystrophin |
| XL cardio-skeletal (Barth syndrome) | Xq28 (gene G4.5) | Tafazzin |
| Approach | Findings | Conclusion |
| Clinical suspicion | Infants and young children: Shortness of breath, feeding difficulties, wheezing, failure to thrive, recurrent chest infections, hepatomegaly, cardiomegaly Older children: Dyspnea, dependent edema, elevated jugular venous pressure, cardiomegaly | Probable heart disease with heart failure |
| Chest radiography | Cardiomegaly, pulmonary plethora, prominent upper lobe veins, pulmonary edema, pleural effusion, collapsed left lower lobe | High probability of heart failure with or without chest infection |
| Electrocardiography | Low-voltage complexes | Pericardial effusion |
| Presence of Q waves and inversion of T waves in leads I, II, aVL, and V4 through V6 (anterolateral infarction pattern) | Anomalous left coronary artery from pulmonary artery | |
| Significant arrhythmia | Dilated cardiomyopathy secondary to arrhythmia | |
| Left ventricular or biventricular hypertrophy with or without left ventricular strain pattern | Often unhelpful | |
| Doppler echocardiographic studies | Significant congenital heart disease | Diagnose primary disease |
| Significant pericardial effusion with satisfactory left ventricular ejection fraction | Diagnose pericardial effusion | |
| Left ventricular posterior wall hypokinesia with hyperechoic papillary muscles, retrograde continuous flow into proximal pulmonary artery | Diagnose anomalous left coronary artery from pulmonary artery | |
| Dilated left ventricle (>95th percentile) with global hypokinesia (fractional shortening < 25%, ejection fraction < 50%), and no demonstrable structural heart disease | Diagnose dilated cardiomyopathy |
| Approach | Findings | Conclusion |
| Clinical features | Positive family history | Genetic cause for dilated cardiomyopathy |
| Acute or chronic encephalopathy, muscle weakness, hypotonia, growth retardation, recurrent vomiting, lethargy | Inborn error of metabolism involving energy production | |
| Coarse or dysmorphic features, organomegaly, skeletal abnormalities, short stature, chronic encephalopathy, cherry-red spot in eyes | Storage diseases | |
| Skeletal muscle weakness without encephalopathy | Neuromuscular disorders | |
| Blood investigations | High blood urea nitrogen and creatinine levels, low calcium and magnesium levels, electrolyte disturbances | Help in the initial management; occasionally point to a cause of dilated cardiomyopathy, especially in neonates |
| Elevated acute-phase reactants and cardiac enzyme levels | Myocarditis | |
| Positive viral titers | Viral myocarditis | |
| Low serum carnitine levels | Systemic carnitine deficiency | |
| Hypoglycemia with low or no acidosis (ketosis) 1. High insulin levels, low free fatty acid 2. Low insulin levels, high free fatty acid | 1. Infant of diabetic mother, nesidioblastosis 2. Defect in fatty acid oxidation or carnitine metabolism | |
| Hypoglycemia with moderate or high acidosis (ketosis) 1. Low or normal lactate and abnormal urine and serum organic acid levels 1. High lactate | 1. Organic (propionic, methylmalonic) acidemias, or ß-ketothiolase deficiency 2. Glycogen storage disease, Bath and Sengers syndromes, pyruvate dehydrogenase deficiency, mitochondrial enzyme deficiency | |
| Hyperammonemia with acidosis | Organic acidemias (as above) | |
| Specific enzyme assay | Confirms enzymatic defect | |
| Absence of above physical and biochemical abnormalities | Post myocarditis or idiopathic dilated cardiomyopathy | |
| Cardiac catheterization | Evaluate hemodynamics | Useful to predict prognosis and evaluate for transplant |
| Coronary angiography | Abnormal origin of left coronary artery from pulmonary artery | Anomalous left coronary artery from pulmonary artery |
| Myocardial biopsy | Myocyte hypertrophy and fibrosis without lymphocytic infiltrate | Dilated cardiomyopathy |
| Inflammatory cell infiltration, cell necrosis | Myocarditis | |
| Special stains | Mitochondrial or infiltrative diseases | |
| Molecular studies (on blood, fibroblasts, or myocardial cells) | Nucleic acid hybridization studies Polymerase chain reaction studies | Myocarditis |
| DNA mutation analysis | Identifies specific genetic defect |

